HDAd6/35++ - A new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells is a research paper published in Molecular Therapy — Methods & Clinical Development (2023). On theSindex it has a DataRank of 0.483. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Bill and Melinda Gates Foundation
Grant: INV-017692
NHLBI
Grant: R01HL128288
NHLBI
Grant: R01HL141781
NIAID NIH HHS
Grant: R01 AI174304
NIDDK NIH HHS
Grant: U54 DK106829
NHLBI NIH HHS
Grant: R01 HL130040
National Institutes of Health
Grant: 5R01HL141781-03
Approach for in vivo gene delivery into hematopoietic stem cells for hemophilia A therapy
Fields of Study
Keywords